Influenza Vs Pneumonia Differences
Published on: January 12, 2025
influenza vs pneumonia differences featured image
Article author photo

Tatiana Abdul Khalek

PhD, <a href="https://www.aru.ac.uk/" rel="nofollow">Anglia Ruskin University, UK</a>

Article reviewer photo

Nour Asaad

MSc Applied Biomolecular Technology, BSc Biochemistry and Molecular Medicine, The University of Nottingham

Overview

Viral and bacterial infections and diseases have caused a massive effect on our lives, ranging from mild flu to more severe illnesses that can even result in death.1 In this article, we will discuss influenza and pneumonia and how they differ.

So, what is influenza? It is usually referred to as the flu and causes mild to severe illnesses.2 It is an acute respiratory infection and affects us worldwide.3 There are different types and pandemics related to influenza that we will further discuss in the sections below.

The next part of this article is about pneumonia. To put it short, it is an inflammation of the lungs due to infection.4 As with influenza, pneumonia can be either mild or severe, with some individuals being more susceptible than others (such as the elderly and children).4 Further information about pneumonia will be discussed in this article as well.

Influenza

Overview and Origin

Influenza, or the flu, is a respiratory infection that has caused multiple pandemics in the past – the first one was known as the Spanish flu in 1918 and was caused by influenza A(H1N1) virus.5 Other forms of influenza include A(H2N2) virus (Asian flu, 1957), A(H3N2) virus (Hong Kong flu, 1968), and A(H1N1)pdm09 virus (swine flu, 2009).5 At the present date, A(H1N1)pdm09 and A(H3N2) viruses along with influenza B virus (Yamagata and Victorian lineages) cause seasonal flu, but the A(H1N1) and A(H2N2) viruses no longer appear.5 

The influenza virus is a negative-strand RNA virus and has 4 distinct types: influenza A, B, C and D:

  • Influenza A: infects different species like humans, swine, horses, and birds. It is more capable of mutations and antigenic variation than the other types making it the major cause of pandemics. It is the most virulent and can cause death3,6
  • Influenza B: causes seasonal flu epidemic in humans6
  • Influenza C: does not cause an epidemic and only causes mild symptoms6
  • Influenza D: infects sheep, swine, and cattle. It is not seen to cause disease in humans6

Symptoms, complications and risk factors

There are multiple symptoms associated with influenza and they include:2,7

  • Fever/chills
  • Dry cough
  • Sore throat
  • Runny nose
  • Muscle and body aches
  • Headache
  • Sleep difficulties
  • Diarrhoea (more common in children)
  • Fatigue

Influenza usually causes uncomplicated infections that persist for 2-8 days.3 However, a set of patients, mostly children, elderly and people with pre-existing illnesses (e.g. kidney and liver disease, asthma, sickle cell anaemia) may experience complications due to viral or secondary bacterial pneumonia with respiratory/multiorgan failure.3 Some of the other complications are listed in Table 1.3

Table 1. Complications of influenza

Cardiovascular- Myocarditis
- Ischemic heart disease
Haematologic- Haemolytic uremic syndrome
- Hemophagocytic syndrome
- Thrombotic thrombocytopenic purpura
Musculoskeletal- Myositis
- Rhabdomyolysis
Neurologic- Encephalomyelitis
- Reye syndrome
- Transverse myelitis
Ocular- Conjunctivitis
- Optic neuritis
- Retinopathy
- Uveal effusion syndrome
Pulmonary- Acute respiratory distress syndrome
- Hypoxic respiratory failure
- Secondary bacterial pneumonia
Renal- Acute kidney injury
- Multiorgan failure

Diagnosis and treatment

It is hard to distinguish flu from other viral or bacterial infections in the lungs using symptoms alone.2 Hence more diagnostic tests are required, such as ‘rapid influenza diagnostic tests’ (RIDTs). RIDTs operate by testing for the viral antigens that cause an immune response.8 However, RIDTs are not as accurate as other tests e.g. ‘rapid molecular assays’. Rapid molecular assays are used to detect the genetic material of the influenza virus.8

Once faced with influenza, there are a few things that can be done to treat it:2,7

Prevention

There are a few steps that can be taken to prevent the spread of infection with influenza:2,7

  • Wash hands regularly
  • Avoid contact with sick individuals
  • Taking flu vaccines
  • Covering coughs/sneezes
  • Bin tissues as soon as they are used

Pneumonia

Overview and Origin

Pneumonia is a big health concern that is linked to short and long-term mortality.9 It is the leading cause of death among all ages worldwide in the infectious disease department.9 In severe pneumonia cases, patients that survive have significant changes such as alteration of the lung function, reduced mental and cognitive functions, fatigue and even reduced motor function.9

Generally, pneumonia is linked to infection, however pathologically speaking it is any inflammatory process that involves the alveolar spaces.10 There are different types of pneumonia:9 

CAP (Community-acquired pneumonia)

There are multiple risk factors for CAP such as age and gender, and medical conditions like autoimmune and heart diseases, which affect the identification of CAP.11

HAP (Hospital-acquired pneumonia) 

This is a common infection in hospitals and is considered the second most common nosocomial infection which causes inflammation in the parenchyma. It is commonly encountered in patients who have been in the intensive care unit (ICU) for at least 48 hours.11

VAP (Ventilator-associated pneumonia)

This is considered one of the deadliest nosocomial infections. VAP develops within 48-72 hours after the placement of artificial airways for mechanical ventilation in the patient.11 

There are different causative agents for pneumonia; for example, Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa and, Klebsiella pneumoniae (which can also be a causative agent for HAP).11 

In cases of VAP, the intubation can become a breeding ground for bacteria and thus lead to pneumonia.11 Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii and, Staphylococcus aureus (including MRSA) are some of the causing agents for VAP.11 Pneumonia can also develop due to a viral infection rather than a bacterial origin, like influenza.12

Symptoms and complications

When pneumonia occurs, there are several symptoms associated with it including:12

  • Fever
  • Cough with yellow, greenish or even bloody mucus
  • Shortness of breath
  • Chills and sweating
  • Shallow breathing
  • Sharp/stabbing chest pain that worsens upon deep breathing or coughing
  • Loss of appetite
  • Nausea/vomiting
  • Confusion (mostly in the elderly)

In addition, some complications can arise in patients with pneumonia such as:13

Diagnosis and treatment

To diagnose pneumonia, the symptoms and patient history are taken along with a physical examination.11

It is important to have the proper diagnosis as other conditions may mimic pneumonia and present themselves with fever and pulmonary infiltrates such as pulmonary embolism and oedema, and even lung cancer.9

 Some of the diagnostic tests include:12

  • Blood tests are done to confirm the presence of an infection to identify the microorganism causing the illness
  • Chest X-rays are done to locate and examine the extent of inflammation in the lungs
  • Pulse oximetry is done to measure the oxygen level in the blood, this is because pneumonia can hinder the lungs from moving enough oxygen into the bloodstream
  • A sputum test is done using a sample of mucus or sputum taken after a deep cough for lab analysis and identification of the infection

People who are considered high-risk individuals (such as children, elderly or immunocompromised/have other medical issues) may require additional tests for confirmation and to avoid complications, some of these tests include:

  • CT scans are more sensitive and give a better view of the lungs in cases of a negative chest radiograph9
  • Arterial blood gas tests are done to test levels of oxygen in a blood sample taken from the arteries (usually the wrist). This is a more accurate test than pulse oximetry12
  • Pleural fluid culture is done by taking a small sample of fluid from tissues surrounding the lungs for microorganism identification12
  • Bronchoscopy is done to look into the airways of the lungs to check for any blockages12

Once pneumonia is diagnosed, treatment can be commenced. This includes:4,14

  • Symptomatic treatment: staying hydrated, getting plenty of rest and using medication to treat the fever
  • Antibiotics in cases of bacterial pneumonia
  • Antiviral drugs in cases of viral pneumonia
  • Pneumococcal vaccine

Prevention

Prevention of pneumonia can be done through multiple measures, including:15

  • Pneumococcal vaccine
  • Washing hands regularly
  • Avoid smoking
  • Maintaining good health habits e.g. exercise, diet
  • Managing existing health conditions such as diabetes, asthma or COPD

Summary

Influenza and pneumonia go hand in hand, while influenza is due to a viral cause, pneumonia can be either viral or bacterial and even present itself in an influenza infection. Both these illnesses can develop into severe cases and cause death and morbidity. Although the treatment is simple, it is important to have the proper diagnosis and treatment for the case at hand, more so in patients who are at high risk.

References

  1. Song Y, Ren F, Sun D, Wang M, Baker JS, István B, et al. Benefits of exercise on influenza or pneumonia in older adults: a systematic review. International Journal of Environmental Research and Public Health [Internet]. 2020 Jan [cited 2024 Apr 26];17(8):2655. Available from: https://www.mdpi.com/1660-4601/17/8/2655
  2. Boktor SW, Hafner JW. Influenza. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK459363/.
  3. Gaitonde DY, Moore FC, Morgan MK. Influenza: diagnosis and treatment. AFP [Internet]. 2019 Dec 15 [cited 2024 Apr 26];100(12):751–8. Available from: https://www.aafp.org/pubs/afp/issues/2019/1215/p751.html
  4. Jain V, Vashisht R, Yilmaz G, Bhardwaj A. Pneumonia Pathology. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK526116/.
  5. Yamayoshi S, Kawaoka Y. Current and future influenza vaccines. Nat Med [Internet]. 2019 Feb [cited 2024 Apr 26];25(2):212–20. Available from: https://www.nature.com/articles/s41591-018-0340-z
  6. Nuwarda RF, Alharbi AA, Kayser V. An overview of influenza viruses and vaccines. Vaccines [Internet]. 2021 Sep [cited 2024 Apr 26];9(9):1032. Available from: https://www.mdpi.com/2076-393X/9/9/1032
  7. Moghadami M. A Narrative Review of Influenza: A Seasonal and Pandemic Disease. Iran J Med Sci [Internet]. 2017 [cited 2025 Jan 13]; 42(1):2–13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337761/.
  8. 1. Vemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I. Current Approaches for Diagnosis of Influenza Virus Infections in Humans. Viruses [Internet]. 2016 [cited 2025 Jan 13]; 8(4):96. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848591/.
  9. Cillóniz C, Torres A, Niederman MS. Management of pneumonia in critically ill patients. BMJ [Internet]. 2021 Dec 6 [cited 2024 Apr 26];375:e065871. Available from: https://www.bmj.com/content/375/bmj-2021-065871
  10. Waterer G. What is pneumonia? Breathe [Internet]. 2021 Sep 1 [cited 2024 Apr 26];17(3). Available from: https://breathe.ersjournals.com/content/17/3/210087
  11. Zade PB, Farahani A, Riyahi M, Lalabadi A, Asl AS, Montazerghaem S. A literature review on hospital-acquired pneumonia, community-acquired pneumonia, and ventilator-associated pneumonia. Gene Cell Tissue [Internet]. 2022 [cited 2024 Apr 26];9(2). Available from: https://brieflands.com/articles/gct-116869
  12. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med [Internet]. 2019 [cited 2025 Jan 13]; 200(7):e45–67. Available from: https://www.atsjournals.org/doi/10.1164/rccm.201908-1581ST.
  13. Alshahwan SI, Alsowailmi G, Alsahli A, Alotaibi A, Alshaikh M, Almajed M, et al. The prevalence of complications of pneumonia among adults admitted to a tertiary care center in Riyadh from 2010-2017. Ann Saudi Med [Internet]. 2019 Jan [cited 2024 Apr 26];39(1):29–36. Available from: http://www.annsaudimed.net/doi/10.5144/0256-4947.2019.29 
  14. El Moussaoui R, Opmeer BC, Borgie CAJM de, Nieuwkerk P, Bossuyt PMM, Speelman P, et al. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest. 2006; 130(4):1165–72. Available from: https://publications.ersnet.org/content/erj/49/6/1700571
  15. Niederman MS. Strategies for the Prevention of Pneumonia. Clinics in Chest Medicine [Internet]. 1987 [cited 2025 Jan 13]; 8(3):543–56. Available from: https://www.sciencedirect.com/science/article/pii/S0272523121010467.
Share

Tatiana Abdul Khalek

PhD, Anglia Ruskin University, UK

I am a PhD student in Biomedical Science at Anglia Ruskin university and work as a quality control (QC) analyst (microbiology/chemistry) at EuroAPI. I have a MSc in Forensic Science from Anglia Ruskin (Cambridge) and I had experience in different roles such as quality lab technician at Fluidic Analytics, Research Assistant/Lab Manager at Cambridge University and Forensic Analyst at the The Research Centre in Topical Drug Delivery and Toxicology, University of Hertfordshire.

My PhD revolves around the use of nanoparticles and their role in cartilage degradation, as well as their potential as drug delivery vehicles for the treatment of diseases such as leukaemia.

arrow-right